Sandwich-type electrochemical immunosensor constructed using three-dimensional lamellar stacked CoS2@C hollow nanotubes prepared by template-free method to detect carcinoembryonic antigen

Electrochemical bio- and chemosensors for cancer biomarkers: Natural (with antibodies) versus biomimicking artificial (with aptamers and molecularly imprinted polymers) recognition

Electrochemical (EC) bio- and chemosensors are highly promising for on-chip and point-of-care testing (POST) devices. They can make a breakthrough in early cancer diagnosis. Most current EC sensors for cancer biomarkers' detection and determination use natural antibodies as recognition units. However, those quickly lose their biorecognition ability upon exposure to harsh environments, comprising extreme pH, humidity, temperature, etc. So-called "plastic antibodies," including aptamers and molecularly imprinted polymers (MIPs), are hypothesized to be a smart alternative to antibodies. They have attracted the interest of the sensor research community, offering a low cost-to-performance ratio with high stability, an essential advantage toward their commercialization. Herein, we critically review recent technological advances in devising and fabricating EC bio- and chemosensors for cancer biomarkers, classifying them according to the type of recognition unit used into three categories, i.e., antibody-, aptamer-, and MIP-based EC sensors for cancer biomarkers. Each sensor fabrication strategy has been discussed, from the devising concept to cancer sensing applications, including using different innovative nanomaterials and signal transduction strategies. Moreover, employing each recognition unit in the EC sensing of cancer biomarkers has been critically compared in detail to enlighten each recognition unit's advantages, effectiveness, and limitations.

Electrochemical immunosensor based on hollow porous Pt skin AgPt alloy/NGR as a dual signal amplification strategy for sensitive detection of Neuron-specific enolase

Neuron-specific enolase (NSE) is a specific marker for small cell carcinoma (SCLC). Sandwich-type electrochemical immunosensors are powerful for biomarker analysis, and the electrocatalytic activity of the signal amplification platform and the performance of the substrate are critical to their sensitivity. In this work, N atom-doped graphene functionalized with hollow porous Pt-skin Ag-Pt alloy (HP-Ag/Pt/NGR) was designed as a dual signal amplifier. The hollow porous Pt skin structure improves the atomic utilization and the larger internal cavity spacing significantly increases the number of electroactive centers, thus exhibiting more extraordinary electrocatalytic activity and durability for H₂O₂ reduction. Using NGR with good catalytic activity as the support material of HP-Ag/Pt, the double amplification of the current signal is realized. For the substrate, polypyrrole-poly(3,4-ethylenedioxythiophene) (PPy-PEDOT) nanotubes were synthesized by a novel chemical polymerization route, which effectively increased the interfacial electron transfer rate. By coupling Au nanoparticles (Au NPs) with PPy-PEDOT, the immune activity of biomolecules is maintained and the conductivity is further enhanced. Under optimal conditions, the linear range was 50 fg mL^-1 - 100 ng mL^-1, and the limit of detection (LOD) was 18.5 fg mL^-1. The results confirm that the developed immunosensor has great promise for the early clinical diagnosis of SCLC.

Responsive-released strategy based on lead ions-dependent DNAzyme functionalized UIO-66-NH2 for tumor marker

Signal labeling on electrode interface is an important step during the construction of immunosensor and most signal substances are directly affixed on the immunoprobe or substrate so that some problems such as flimsy labeling method and interference of insulating proteins on electrode surface have been existed to affect their readout. In order to solve above problems in electrochemical immunoassay, a lead ions-decodable autocephalous signal integrator based on UIO-66-NH₂ was proposed for the detection of prostate specific antigen (PSA). Briefly, a lead ions-dependent DNAzyme functionalized UIO-66-NH₂, in which methylene blue was encapsulated, was independently dispersed in solution phase to be closely associated with the lead sulfide labeled sandwich bioconjugates, and internal methylene blue molecules can be sustained released once a cationic exchange reaction was occurred between lead sulfide label and adscititious silver ions. Based on this designing, immunoassay for PSA was effectively connected with the dynamic behavior of methylene blue molecules through the cleavage of DNAzyme on MOFs surface and performed a wide linear range from 1 pg mL^-1 to 10 ng mL^-1 and a satisfactory detection limit with 0.34 pg mL^-1. The proposed strategy was expected to offer more valuable information for the application of MOFs in early and accurate cancer diagnosis.

Electrochemistry/Photoelectrochemistry-Based Immunosensing and Aptasensing of Carcinoembryonic Antigen

Recently, electrochemistry- and photoelectrochemistry-based biosensors have been regarded as powerful tools for trace monitoring of carcinoembryonic antigen (CEA) due to the fact of their intrinsic advantages (e.g., high sensitivity, excellent selectivity, small background, and low cost), which play an important role in early cancer screening and diagnosis and benefit people's increasing demands for medical and health services. Thus, this mini-review will introduce the current trends in electrochemical and photoelectrochemical biosensors for CEA assay and classify them into two main categories according to the interactions between target and biorecognition elements: immunosensors and aptasensors. Some recent illustrative examples are summarized for interested readers, accompanied by simple descriptions of the related signaling strategies, advanced materials, and detection modes. Finally, the development prospects and challenges of future electrochemical and photoelectrochemical biosensors are considered.

The application of the inexpensive and synthetically simple electrocatalyst CuFe-MoC@NG in immunosensors

In this study, we used inexpensive and synthetically simple electrocatalysts as replacements for conventional precious metal materials to reduce hydrogen peroxide (H₂O₂). We for the first time developed N-doped graphene-coated CuFe@MoC using one-step calcination of binary Prussian blue analogues (PBAs) with Mo⁶⁺ cationic grafting precursors. The synergistic interaction of CuFe PBA and MoC increased the catalytically active sites for H₂O₂ reduction. The catalyst was optimized in terms of the ratio of CuFe PBA to Mo⁶⁺, PVP content, and calcination temperature to improve its catalytic activity. When it was used to construct an electrochemical immunosensor for carcinoembryonic antigen (CEA) detection, polydopamine (CuFe-MoC@NG@PDA) was coated on its outer surface to increase the antibody loading and MoS₂-Au NPs were used as substrates to improve Ab₁ immobilization and accelerate electron transfer at the electrode interface, thereby improving the response signal of the immunosensor. Its concentration was linearly related to the response signal from 10 fg mL^-1 to 80 ng mL^-1, and the lowest limit of detection was 3 fg mL^-1. In addition, the immunosensor has acceptable selectivity and high stability. All data indicate that nanocomposites have electrocatalytic applications.

Ultrasensitive detection of cyclin D1 by a self-enhanced ECL immunosensor based on Bi2S3 quantum dots

Bismuth sulfide quantum dots (Bi₂S₃ QDs), which have excellent optical and thermoelectric properties, represent a green and non-toxic semiconductor material that has been widely used in catalysis and photoelectric conversion devices. At present, research on this material has gradually expanded into the biological field. Herein, the biomineralization method mediated by bovine serum albumin (BSA) was utilized to synthesize Bi₂S₃ QDs with monodispersity, excellent colloidal stability, and good biocompatibility. This is the first study on the electrochemiluminescence (ECL) characteristics of Bi₂S₃ QDs and related ECL mechanisms in detail. In addition, on the basis of Bi₂S₃ QDs, an ECL immunosensor was used for the ultrasensitive measurement of cyclin D1 (CCND1). The composite material, namely Au@Cu-Bi₂S₃ QDs was used as a high-sensitivity ECL probe, in which AuNPs were connected with Bi₂S₃ QDs through a copper(ii) ion bridge. PDA-AgNPs made of dopamine (DA) and silver nanoparticles (AgNPs) were utilized as a carrier for fixing the primary antibody (Ab₁), ultimately presenting a relatively wide detection range of 10 fg mL^-1-1 μg mL^-1. Moreover, quite a low detection limit (6.34 fg mL^-1) was also obtained for an assay of CCND1. Results indicated that the immunosensor can provide a potential platform with fine stability and creditable reproducibility for clinical diagnosis.

Electrochemical biosensors for measurement of colorectal cancer biomarkers

Colorectal cancer (CRC) is associated with one of the highest rates of mortality among cancers worldwide. The early detection and management of CRC is imperative. Biomarkers play an important role in CRC screening tests, CRC treatment, and prognosis and clinical management; thus rapid and sensitive detection of biomarkers is helpful for early detection of CRC. In recent years, electrochemical biosensors for detecting CRC biomarkers have been widely investigated. In this review, different electrochemical detection methods for CRC biomarkers including immunosensors, aptasensors, and genosensors are summarized. Further, representative examples are provided that demonstrate the advantages of electrochemical sensors modified by various nanomaterials. Finally, the limitations and prospects of biomarkers and electrochemical sensors in detection are also discussed. Graphical abstract.

Electrochemical immunosensor based on Au/Co-BDC/MoS2 and DPCN/MoS2 for the detection of cardiac troponin I

The content of cardiac troponin I (CTnI) in human blood is the key factor in judging acute myocardial infarction (AMI). In order to detect the content of CTnI, we constructed a sandwich-type electrochemical immunosensor based on hydrogen peroxide (H₂O₂) as a signal source. Dendritic platinum-copper alloy nanoparticles (DPCN) loaded on molybdenum disulfide (MoS₂) nanosheets (DPCN/MoS₂) as secondary antibodies (Ab₂) label provided signal amplification. The hollow three-dimensional (3D) pyramid-shaped structure of DPCN exposed abundant active sites and exhibited excellent catalytic properties. MoS₂ nanosheets with flower-like structure and a larger specific surface area can effectively load more DPCN. The combination of MoS₂ and DPCN enhanced the catalytic performance of DPCN/MoS₂ towards H₂O₂ reduction and realized signal amplification. For the substrate material, the two-dimensional (2D) metal-organic framework (Co-BDC, 1,4-benzenedicarboxylate is abbreviated as BDC) was hybridized with MoS₂ nanosheets to load gold nanoparticles (Au NPs). The obtained Au/Co-BDC/MoS₂ had low catalytic activity and excellent electrical conductivity, which was used to load primary antibodies (Ab₁) to effectively enhance the sensitivity. Under the best conditions, we constructed the immunosensor with the detection range of 10 fg/mL to 100 ng/mL and the limit of detection (LOD) of 3.02 fg/mL. At the same time, the content of CTnI in human serum was tested with satisfactory results. Therefore, the constructed immunosensor has important significance in the sensitive and accurate detection of CTnI and early diagnosis of AMI.

Advances in immunosensor technology

In recent years, advances in immunosensor device fabrication have significantly expanded the use of this technology in a broad range of applications including clinical diagnosis, food analysis, quality control, environmental studies and industrial monitoring. The most important aspect in fabrication is to obtain a design that provides a low detection limit. The utilization of nanomaterials as a label, catalyst and biosensing transducer is, perhaps, the most popular approach in ultrasensitive devices. This chapter reviews recent advances in immunosensor fabrication and summarizes the most recent studies. Strategies employed to significantly improve sensitivity and specificity of immunosensor technology and the advantages and limitations thereof are explored.

Bimetallic PtCu nanoparticles supported on molybdenum disulfide-functionalized graphitic carbon nitride for the detection of carcinoembryonic antigen

A molybdenum disulfide based graphite phase carbon nitride (MoS₂/g-C₃N₄) which is supported by a platinum-copper nanoparticle (PtCu) Z-type catalyst was created in this study. The catalyst exploits optoelectronic synergistic effect with large surface area, good catalysis, and biocompatibility to amplify the signal. The electrode impedance of the synthesized MoS₂/g-C₃N₄-PtCu was reduced five times in visible light compared with dark conditions, thereby improving the detection of carcinoembryonic antigen (CEA). At a voltage of - 0.4 V, the immunoprobe constructed with this material is used for CEA detection. A linear relationship between 100 fg mL^-1 and 80 ng mL^-1 concentrations was achieved with a minimum detection limit of 33 fg mL^-1 (S/N = 3). The recovery rate was 103-104%, and the relative standard deviation was 2.9-3.8%. This implies that the sandwich immunosensors have good reproducibility, selectivity, and stability and can be used in various applications. Graphical Abstract.

A novel electrochemical immunosensor based on CoS2 for early screening of tumor marker carcinoembryonic antigen

In this work, PANI–HRP nanoparticles integrate biometric recognition and signal amplification functions in one body, which can be converted to each other without consuming the material itself.